{"content":"<li class=\"n-box-item date-title\" data-end=\"1472875199\" data-start=\"1472788800\" data-txt=\"Sunday, December 22, 2019\">Friday, September  2, 2016</li><li class=\"n-box-item sa-box-item\" data-id=\"3206954\" data-ts=\"1472857523\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTR\" target=\"_blank\">NTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3206954-potash-agrium-tie-up-may-face-better-regulatory-odds-in-canada-u-s\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Potash-Agrium tie-up may face better regulatory odds in Canada than U.S.</a></h4><ul>   <li>A combination of Potash (<a href=\"https://seekingalpha.com/symbol/POT\" target=\"_blank\">POT</a> <font color=\"green\">+1%</font>) and Agrium (<a href=\"https://seekingalpha.com/symbol/AGU\" target=\"_blank\">AGU</a> <font color=\"green\">+1.6%</font>) into a <a href=\"https://seekingalpha.com/news/3206148-potash-agrium-confirm-preliminary-merger-talks\" target=\"_blank\">fertilizer giant</a> may find a <a href=\"http://www.reuters.com/article/us-agrium-m-a-potashcorp-idUSKCN1182J3\" target=\"_blank\">friendlier regulatory ear</a> in the companies' home country of Canada than it would in the United States, competition lawyers say, but a U.S. rejection would kill the deal just the same.</li>    <li>Canada's Competition Bureau may be kinder since its regulators focus more on the potential for achieving efficiencies of scale -- the better to strengthen companies usually already operating in a smaller market.</li>    <li>But significant operations in the U.S. mean the FTC or Justice Dept. could take a harder line on what Potash/Agrium would mean for pricing power. Such a merger would consolidate 62% of North American potash production into one company and reduce the market largely to two companies overall.</li>    <li>Earlier this year, Canadian regulators approved a deal between Superior Plus and Canexus on the efficiency argument, but U.S. denial scuttled the deal.</li>    <li>Just yesterday, agricultural producers representative Norm Hall compared the situation to \"<a href=\"https://seekingalpha.com/news/3206567-farmers-ready-turn-regulators-potash-agrium-deal\" target=\"_blank\">the movie 'Mad Max'</a> -- one company owns everything,\" suggesting they'd head to the Competition Bureau to oppose a deal.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3206954\" data-linked=\"Potash-Agrium tie-up may face better regulatory odds in Canada than U.S.\" data-tweet=\"$NTR - Potash-Agrium tie-up may face better regulatory odds in Canada than U.S. https://seekingalpha.com/news/3206954-potash-agrium-tie-up-may-face-better-regulatory-odds-in-canada-u-s?source=tweet\" data-url=\"https://seekingalpha.com/news/3206954-potash-agrium-tie-up-may-face-better-regulatory-odds-in-canada-u-s\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3206949\" data-ts=\"1472852249\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNIT\" target=\"_blank\">UNIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3206949-communications-sales-leasing-sets-250m-equity-offering-program\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Communications Sales &amp; Leasing sets $250M equity offering program</a></h4><ul>   <li>Communications Sales &amp; Leasing (<a href=\"https://seekingalpha.com/symbol/CSAL\" target=\"_blank\">CSAL</a> <font color=\"green\">+1.8%</font>) has put together an equity offering to sell up to $250M worth in shares.</li>    <li>The \"at the market\" offering comes through equity distribution deals with BofA Merrill Lynch, Goldman Sachs, Morgan Stanley, and Wells Fargo.</li>    <li>With \"substantial liquidity,\" the company doesn't plan to use the program immediately, but says it offers additional flexibility for financing purposes \"including for acquisitions.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3206949\" data-linked=\"Communications Sales &amp; Leasing sets $250M equity offering program\" data-tweet=\"$UNIT - Communications Sales &amp; Leasing sets $250M equity offering program https://seekingalpha.com/news/3206949-communications-sales-leasing-sets-250m-equity-offering-program?source=tweet\" data-url=\"https://seekingalpha.com/news/3206949-communications-sales-leasing-sets-250m-equity-offering-program\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3206948\" data-ts=\"1472852125\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3206948-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/REN' title='Resolute Energy Corporation'>REN</a> <font color='green'>+3.2%</font>. <a href='https://seekingalpha.com/symbol/PNNT' title='PennantPark Investment'>PNNT</a> <font color='green'>+2.7%</font>. <a href='https://seekingalpha.com/symbol/HPJ' title='Highpower International, Inc.'>HPJ</a> <font color='green'>+2.5%</font>. <a href='https://seekingalpha.com/symbol/KPTI' title='Karyopharm Therapeutics Inc.'>KPTI</a> <font color='green'>+1.7%</font>. <a href='https://seekingalpha.com/symbol/TEF' title='Telefonica S.A.'>TEF</a> <font color='green'>+1.5%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/STM' title='STMicroelectronics NV'>STM</a> <font color='red'>-5.0%</font>. <a href='https://seekingalpha.com/symbol/SXCP' title='SunCoke Energy Partners'>SXCP</a> <font color='red'>-3.3%</font>. <a href='https://seekingalpha.com/symbol/COTY' title='Coty Inc.'>COTY</a> <font color='red'>-2.1%</font>. <a href='https://seekingalpha.com/symbol/ARWR' title='Arrowhead Pharmaceuticals'>ARWR</a> <font color='red'>-2.1%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3206948\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$REN $PNNT $HPJ - After Hours Gainers / Losers https://seekingalpha.com/news/3206948-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3206948-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3206939\" data-ts=\"1472848996\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSTG\" target=\"_blank\">PSTG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3206939-new-trial-granted-to-pure-storage-in-emc-patent-case-14m-verdict-set-aside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New trial granted to Pure Storage in EMC patent case, $14M verdict set aside</a></h4><ul>\n<li>Pure Storage (NYSE:<a href=\"https://seekingalpha.com/symbol/PSTG\" title=\"Pure Storage\">PSTG</a>) <a href=\"http://www.wsj.com/articles/pure-storage-wins-new-trial-in-emc-patent-case-1472846130\" target=\"_blank\">registered</a> somewhat of a victory this week in a case that has been ongoing since 2013. A federal judge has ordered a new trial and held back the $14M figure <a href=\"http://www.wsj.com/articles/emc-wins-partial-patent-victory-against-pure-storage-1458090762\" target=\"_blank\">originally ruled</a> in March.</li>\n<li>Pure's general counsel: \"We continue to believe that we will ultimately prevail in the patent infringement case\u2014and today\u2019s ruling is a major step in that direction.\"</li>\n<li>A new trial is issued to discern validity of a key disputed component Pure argues was already protected by a 2002 Sun Microsystems patent.</li>\n<li>Pure Storage closed <font color=\"green\">up 2.3%</font> today while EMC (EMC) closed <font color=\"red\">0.35%</font> lower ahead of next week's conclusion of its merger with Dell.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3206939\" data-linked=\"New trial granted to Pure Storage in EMC patent case, $14M verdict set aside\" data-tweet=\"$PSTG $PSTG $DELL - New trial granted to Pure Storage in EMC patent case, $14M verdict set aside https://seekingalpha.com/news/3206939-new-trial-granted-to-pure-storage-in-emc-patent-case-14m-verdict-set-aside?source=tweet\" data-url=\"https://seekingalpha.com/news/3206939-new-trial-granted-to-pure-storage-in-emc-patent-case-14m-verdict-set-aside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3206943\" data-ts=\"1472848755\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LEE\" target=\"_blank\">LEE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3206943-wilson-becomes-chairman-ward-ceo-of-lee-unit-townnews-com\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wilson becomes chairman, Ward CEO of Lee unit TownNews.com</a></h4><ul>   <li>Marc Wilson has been named executive chairman of TownNews.com, the unit of Lee Enterprises (<a href=\"https://seekingalpha.com/symbol/LEE\" title=\"Lee Enterprises, Incorporated\">LEE</a> <font color=\"green\">+9.5%</font>) formerly known as the International Newspaper Network.</li>    <li>Wilson is currently the CEO; he'll give up that post to Brad Ward, currently the company's chief operating officer, effective Oct. 1.</li>    <li>Ward joined TownNews.com in 2000. The subsidiary provides regional publishing technology across the country.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3206943\" data-linked=\"Wilson becomes chairman, Ward CEO of Lee unit TownNews.com\" data-tweet=\"$LEE - Wilson becomes chairman, Ward CEO of Lee unit TownNews.com https://seekingalpha.com/news/3206943-wilson-becomes-chairman-ward-ceo-of-lee-unit-townnews-com?source=tweet\" data-url=\"https://seekingalpha.com/news/3206943-wilson-becomes-chairman-ward-ceo-of-lee-unit-townnews-com\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3206942\" data-ts=\"1472848390\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCOR\" target=\"_blank\">SCOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3206942-comscore-gets-delisting-deadline-from-nasdaq-over-late-filings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ComScore gets delisting deadline from Nasdaq over late filings</a></h4><ul>    <li>ComScore (<a href=\"https://seekingalpha.com/symbol/SCOR\" title=\"comScore, Inc.\">SCOR</a> <font color=\"green\">+1.8%</font>) -- facing numerous delays in filing required financials this year amid a lengthy accounting probe -- has received a new letter from Nasdaq threatening a trading suspension and delisting as soon as Sept. 12.</li>    <li>The company will need to request a hearing by next Thursday, and intends to do so and present a plan to regain compliance.</li>    <li>It will also ask for a stay of the trading suspension and delisting during the appeals process.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3204413-comscore-gets-expected-deficiency-notice-late-filings\" target=\"_blank\">ComScore gets expected deficiency notice over late filings</a> (Aug. 18 2016)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3202151-comscore-names-new-ceo-cfo-delays-quarterly-filing-amid-probe\" target=\"_blank\">ComScore names new CEO, CFO; delays quarterly filing amid probe</a> (Aug. 10 2016)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3206942\" data-linked=\"ComScore gets delisting deadline from Nasdaq over late filings\" data-tweet=\"$SCOR - ComScore gets delisting deadline from Nasdaq over late filings https://seekingalpha.com/news/3206942-comscore-gets-delisting-deadline-from-nasdaq-over-late-filings?source=tweet\" data-url=\"https://seekingalpha.com/news/3206942-comscore-gets-delisting-deadline-from-nasdaq-over-late-filings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3206936\" data-ts=\"1472847463\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3206936-weekly-etf-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weekly ETF Gainers / Losers</a></h4><ul>     <li> <b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/EWZ\" title=\"iShares MSCI Brazil Capped ETF\">EWZ</a> <font color=\"green\">+4.31%</font>. <a href=\"https://seekingalpha.com/symbol/KOL\" title=\"VanEck Vectors Coal ETF\">KOL</a> <font color=\"green\">+4.24%</font>. <a href=\"https://seekingalpha.com/symbol/PSLV\" title=\"Sprott Physical Silver Trust\">PSLV</a> <font color=\"green\">+4.21%</font>. <a href=\"https://seekingalpha.com/symbol/SLV\" title=\"iShares Silver Trust ETF\">SLV</a> <font color=\"green\">+4.05%</font>. <a href=\"https://seekingalpha.com/symbol/EPI\" title=\"WisdomTree India Earnings ETF\">EPI</a> <font color=\"green\">+3.9%</font>.  </li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/OIL\" title=\"iPath S&amp;P Crude Oil Total Return Index ETN\">OIL</a> <font color=\"red\">-6.99%</font>. <a href=\"https://seekingalpha.com/symbol/BNO\" title=\"The United States Brent Oil ETF, LP\">BNO</a> <font color=\"red\">-6.48%</font>. <a href=\"https://seekingalpha.com/symbol/USO\" title=\"The United States Oil ETF, LP\">USO</a> <font color=\"red\">-6.48%</font>. <a href=\"https://seekingalpha.com/symbol/VXX\" title=\"iPath S&amp;P 500 VIX Short-Term Futures ETN\">VXX</a> <font color=\"red\">-6.25%</font>. <a href=\"https://seekingalpha.com/symbol/UNG\" title=\"The United States Natural Gas ETF, LP\">UNG</a> <font color=\"red\">-3.52%</font>.   </li> </ul><div class=\"tiny-share-widget\" data-id=\"3206936\" data-linked=\"Weekly ETF Gainers / Losers\" data-tweet=\"$EWZ $KOL $PSLV - Weekly ETF Gainers / Losers https://seekingalpha.com/news/3206936-weekly-etf-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3206936-weekly-etf-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3206931\" data-ts=\"1472846576\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DVAX\" target=\"_blank\">DVAX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3206931-dynavax-plummets-after-ad-comm-review-of-hep-b-vaccine-canceled-shares-down-32\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dynavax plummets after Ad Comm review of hep B vaccine canceled; shares down 32%</a></h4><ul>\n<li>Dynavax (<a href=\"https://seekingalpha.com/symbol/DVAX\" title=\"Dynavax Technologies Corporation\">DVAX</a> <font color=\"red\">-31.7%</font>) gets some rude treatment today. Shares are down on a 29x surge in volume on the <a href=\"https://www.thestreet.com/story/13693559/1/dynavax-technologies-dvax-stock-plummets-on-cancelled-fda-meeting.html?source=sa\" target=\"_blank\">news </a>that the FDA has canceled the November 16 Ad Comm review of the company's BLA seeking approval of its hepatitis B vaccine, Heplisav-B.  The agency says it needs more time to \"review and resolve several outstanding issues.\"</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3200858-dynavaxs-hepatitis-b-candidate-gets-ad-comm-review-nov-16\" target=\"_blank\">Dynavax's hepatitis B candidate gets Ad Comm review Nov. 16</a> (Aug. 5)</li>\n<li>\n<strong>Update</strong>: On September 6, the company issued a <a href=\"https://www.sec.gov/Archives/edgar/data/1029142/000156459016024926/dvax-ex991_6.htm\" target=\"_blank\">statement </a>saying the FDA intends to provide information requests in the coming weeks. The agency indicated that it will review the overall immunogenicity data from the Phase 3 HBV-23 study to support the proposed adult indication but it will not review immunogenicity data related to sub-populations including diabetics because the data were not a direct response to its February 23, 2013 Complete Response Letter (CRL). A Class 2 resubmission, which is what this is, relates only to the issues cited in the CRL. Additional data will need to be submitted as a supplemental BLA following approval. The company says the FDA has communicated that the December 15 PDUFA date should still be achievable.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3206931\" data-linked=\"Dynavax plummets after Ad Comm review of hep B vaccine canceled; shares down 32%\" data-tweet=\"$DVAX - Dynavax plummets after Ad Comm review of hep B vaccine canceled; shares down 32% https://seekingalpha.com/news/3206931-dynavax-plummets-after-ad-comm-review-of-hep-b-vaccine-canceled-shares-down-32?source=tweet\" data-url=\"https://seekingalpha.com/news/3206931-dynavax-plummets-after-ad-comm-review-of-hep-b-vaccine-canceled-shares-down-32\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>77&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3206700\" data-ts=\"1472843563\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SVRA\" target=\"_blank\">SVRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3206700-mast-therapeutics-perks-up-24-data-from-late-stage-study-of-vepoloxamer-in-sickle-cell\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mast Therapeutics perks up 24%; data from late-stage study of vepoloxamer in sickle cell disease due this month</a></h4><ul>\n<li>Micro cap Mast Therapeutics (MSTX <font color=\"green\">+23.7%</font>) heads north on a 4x surge in volume. No particular news accounts for the move, but data from a Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT01737814?term=vepoloxamer&amp;rank=6\" target=\"_blank\">EPIC</a>, assessing lead product candidate vepoloxamer for the treatment of patients with sickle cell disease (SCD) experiencing vaso-occlusive crisis (VOC) are expected this month.</li>\n<li>Investors need to be cautious here. Enrollment was completed in February and the time periods to assess efficacy endpoints were 4 - 14 days which means the company has been \"analyzing\" the data for six months. If the results were clearly positive, the announcement would most likely have been made promptly. According to a <a href=\"http://masttherapeutics.com/about-us/ceo-corner/\" target=\"_blank\">July letter to shareholders</a>, CEO Brian Culley said the company was working diligently to complete the data cleaning, validation and QA/QC work required to lock and unblind the database. Mast is under additional pressure for a positive outcome because it will have to prepay $10M of the principal balance of an outstanding loan if the trial fails.</li>\n<li>\n<a href=\"https://en.wikipedia.org/wiki/Vaso-occlusive_crisis\" target=\"_blank\">VOC</a>, a painful complication of SCD, occurs when the circulation of blood vessels is obstructed by sickled red blood cells. One of the most severe forms of VOC is acute chest syndrome which occurs when blood flow to the lungs is restricted.</li>\n<li>\n<a href=\"http://www.masttherapeutics.com/technology/\" target=\"_blank\">Vepoloxamer </a>is a purified form of a copolymer called <a href=\"https://en.wikipedia.org/wiki/Poloxamer\" target=\"_blank\">poloxamer 188</a>, which selectively adheres to hydrophobic (water repelling) portions of cells and molecules, creating a barrier that inhibits other adhesive hydrophobic interactions. The net pharmacologic effects are improved blood flow, blood clot prevention (fibrinolysis) and reductions in inflammation and thrombosis (blood clotting). On a damaged cell, vepoloxamer restores membrane integrity and provides time for the cell's natural repair mechanisms to restore normal function.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3126476-mast-completes-enrollment-late-stage-study-vepoloxamer-sickle-cell-disease\" target=\"_blank\">Mast completes enrollment in late-stage study of vepoloxamer in sickle cell disease</a> (Feb. 22)</li>\n<li>\n<strong>Clarification</strong>: In March, the company stated that it expected to report top-line data in Q2. In June, it revised its forecast for the database lock to July with the data readout to follow shortly thereafter. In July, it revised the time line again to September. It attributed the delays to the \"multitude of data points in the study and QC/QA procedures \"taking longer than expected.\" [this news item was originally published on Sept. 1]</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3206700\" data-linked=\"Mast Therapeutics perks up 24%; data from late-stage study of vepoloxamer in sickle cell disease due this month\" data-tweet=\"$SVRA - Mast Therapeutics perks up 24%; data from late-stage study of vepoloxamer in sickle cell disease due this month https://seekingalpha.com/news/3206700-mast-therapeutics-perks-up-24-data-from-late-stage-study-of-vepoloxamer-in-sickle-cell?source=tweet\" data-url=\"https://seekingalpha.com/news/3206700-mast-therapeutics-perks-up-24-data-from-late-stage-study-of-vepoloxamer-in-sickle-cell\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>139&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3206926\" data-ts=\"1472842846\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3206926-technology-top-5-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/KONE' title='Kingtone Wirelessinfo Solution Holding Ltd'>KONE</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/APPS' title='Digital Turbine, Inc.'>APPS</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/HLIT' title='Harmonic Inc.'>HLIT</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/MTLS' title='Materialise NV'>MTLS</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/I' title='Intelsat SA'>I</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TCPI' title='TCP International'>TCPI</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/AMBA' title='Ambarella'>AMBA</a> <font color='red'>-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3206926\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3:00 pm\" data-tweet=\"$KONE $APPS $HLIT - Technology - Top 5 Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3206926-technology-top-5-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3206926-technology-top-5-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3206919\" data-ts=\"1472839362\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3206919-energy-materials-top-5-gainers-losers-of-2-15-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:15 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/REN' title='Resolute Energy Corporation'>REN</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/PACD' title='Pacific Drilling SA'>PACD</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/PES' title='Pioneer Energy Services'>PES</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/HNRG' title='Hallador Energy Co'>HNRG</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/DNR' title='Denbury Resources Inc.'>DNR</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> MPET <font color='red'>-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3206919\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:15 pm\" data-tweet=\"$REN $PACD $PES - Energy/Materials - Top 5 Gainers / Losers as of 2:15 pm https://seekingalpha.com/news/3206919-energy-materials-top-5-gainers-losers-of-2-15-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3206919-energy-materials-top-5-gainers-losers-of-2-15-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3206914\" data-ts=\"1472835836\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UAA\" target=\"_blank\">UAA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3206914-under-armourminus-2-ceo-kevin-plank-selling-up-to-2_075m-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Under Armour -2%; CEO Kevin Plank selling up to 2.075M shares</a></h4><ul>\n<li>A pre-arranged plan was disclosed today in an <a href=\"https://seekingalpha.com/filing/3214287\" target=\"_blank\">8-K filing</a> and allows Plank to unload up to 1.875M Class C shares personally and up to 200K Class C shares held by a charitable foundation over a nine month period beginning in October.</li>\n<li>He presently owns 33.8M Class C shares, 34.45M Class B shares and 135K Class A shares.</li>\n<li>The planned sale would mark the CEO's total ownership level at 15.2% of outstanding (as of June 30) class A, B and C Under Armour (<a href=\"https://seekingalpha.com/symbol/UA\" title=\"Under Armour, Inc. Class C\">UA</a> <font color=\"red\">-2.2%</font>) shares over a current 15.6% level.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3206914\" data-linked=\"Under Armour -2%; CEO Kevin Plank selling up to 2.075M shares\" data-tweet=\"$UAA - Under Armour -2%; CEO Kevin Plank selling up to 2.075M shares https://seekingalpha.com/news/3206914-under-armourminus-2-ceo-kevin-plank-selling-up-to-2_075m-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3206914-under-armourminus-2-ceo-kevin-plank-selling-up-to-2_075m-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>41&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3206910\" data-ts=\"1472835642\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3206910-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SIEB' title='Siebert Financial Corp.'>SIEB</a> <font color='green'>+32%</font>. <a href='https://seekingalpha.com/symbol/UBCP' title='United Bancorp, Inc.'>UBCP</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/YRD' title='Yirendai LTD.'>YRD</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/GEO' title='The GEO Group, Inc.'>GEO</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/FCFS' title='First Cash Financial Services, Inc.'>FCFS</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CCCR-OLD' title='China Commercial Credit'>CCCR-OLD</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3206910\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$SIEB $UBCP $YRD - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3206910-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3206910-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3206907\" data-ts=\"1472834614\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3206907-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ACW' title='Accuride Corporation'>ACW</a> <font color='green'>+55%</font>. <a href='https://seekingalpha.com/symbol/SIEB' title='Siebert Financial Corp.'>SIEB</a> <font color='green'>+31%</font>. <a href='https://seekingalpha.com/symbol/KONE' title='Kingtone Wirelessinfo Solution Holding Ltd'>KONE</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/VSR' title='Versar, Inc'>VSR</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/REN' title='Resolute Energy Corporation'>REN</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/PES' title='Pioneer Energy Services'>PES</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/VISN' title='VisionChina Media, Inc.'>VISN</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/HLIT' title='Harmonic Inc.'>HLIT</a> <font color='green'>+12%</font>. THLD <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/CRC' title='California Resources Corporation'>CRC</a> <font color='green'>+11%</font>.</li><li><b>Losers:&nbsp;</b><a href='https://seekingalpha.com/symbol/PAY' title='VeriFone Systems, Inc.'>PAY</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/WLFC' title='Willis Lease Finance Corporation'>WLFC</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/CCXI' title='ChemoCentryx'>CCXI</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/NVET' title='Nexvet Biopharma'>NVET</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/BNTC' title='Benitec'>BNTC</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/TCPI' title='TCP International'>TCPI</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/JAGX' title='Jaguar Animal Health, Inc.'>JAGX</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/SHOS' title='Sears Hometown and Outlet Stores, Inc.'>SHOS</a>&nbsp;<font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/AMBA' title='Ambarella'>AMBA</a>&nbsp;<font color='red'>7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3206907\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$ACW $SIEB $KONE - Midday Gainers / Losers https://seekingalpha.com/news/3206907-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3206907-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3206885\" data-ts=\"1472833959\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3206885-healthcare-top-gainers-losers-of-12-30-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top Gainers / Losers as of 12:30 pm</a></h4><ul>     <li><b>Gainers:</b> THLD <font color='green'>+11%</font>. CPHR <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/OCRX' title='Ocera Therapeutics, Inc.'>OCRX</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/AUPH' title='Aurinia Pharmaceuticals Inc.'>AUPH</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/SPHS' title='Sophiris Bio'>SPHS</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CCXI' title='ChemoCentryx'>CCXI</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/BNTC' title='Benitec'>BNTC</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/JAGX' title='Jaguar Animal Health, Inc.'>JAGX</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/NURO' title='NeuroMetrix, Inc.'>NURO</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/KPTI' title='Karyopharm Therapeutics Inc.'>KPTI</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3206885\" data-linked=\"Healthcare - Top Gainers / Losers as of 12:30 pm\" data-tweet=\"$MTEM $CPHRF $OCRX - Healthcare - Top Gainers / Losers as of 12:30 pm https://seekingalpha.com/news/3206885-healthcare-top-gainers-losers-of-12-30-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3206885-healthcare-top-gainers-losers-of-12-30-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3206906\" data-ts=\"1472833640\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMBA\" target=\"_blank\">AMBA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3206906-oppenheimer-co-restates-ambarella-perform-rating-notes-near-term-volatility\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oppenheimer &amp; Co. restates Ambarella Perform rating, notes near-term volatility</a></h4><ul>\n<li>Trading in Ambarella (<a href=\"https://seekingalpha.com/symbol/AMBA\" title=\"Ambarella\">AMBA</a> <font color=\"red\">-6.8%</font>) was reasonably stable following yesterday's <a href=\"https://seekingalpha.com/news/3206771-ambarella-posts-lower-q2-revenue-decline-forecasted-minus-2-percent-hours\" target=\"_blank\">earnings release</a>, though today a pronounced downside turn has developed.</li>\n<li>Analyst Andrew Uerkwitz <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/09/8419347/ambarellas-underlying-markets-to-produce-volatility-near\" target=\"_blank\">comments</a>: \"We like it as the market leading, pure-play investment that is positioned to benefit from secular growth in demand for analysis of image data. But the two largest underlying markets for AMBA, IP camera and action camera, are likely to provide undesirable volatility in the near term.\"</li>\n<li>Raises FY 2017 revenue projection to $308.7M and EPS to $2.52 while cautioning margins could see pressure. Ambarella forecasts FY 2017 revenue to decline 0%-5% Y/Y.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3206906\" data-linked=\"Oppenheimer &amp; Co. restates Ambarella Perform rating, notes near-term volatility\" data-tweet=\"$AMBA - Oppenheimer &amp; Co. restates Ambarella Perform rating, notes near-term volatility https://seekingalpha.com/news/3206906-oppenheimer-co-restates-ambarella-perform-rating-notes-near-term-volatility?source=tweet\" data-url=\"https://seekingalpha.com/news/3206906-oppenheimer-co-restates-ambarella-perform-rating-notes-near-term-volatility\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3206905\" data-ts=\"1472832941\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3206905-consumer-goods-top-gainers-losers-of-12-15-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer Goods - Top Gainers / Losers as of 12:15 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ACW' title='Accuride Corporation'>ACW</a> <font color='green'>+56%</font>. SPU <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/CXDC' title='China XD Plastics Company Limited'>CXDC</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/NVFY' title='Nova Lifestyle, Inc.'>NVFY</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CHD' title='Church & Dwight Co Inc.'>CHD</a> <font color='red'>-50%</font>. <a href='https://seekingalpha.com/symbol/PAY' title='VeriFone Systems, Inc.'>PAY</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a> <font color='red'>-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3206905\" data-linked=\"Consumer Goods - Top Gainers / Losers as of 12:15 pm\" data-tweet=\"$ACW $FTFT $CXDC - Consumer Goods - Top Gainers / Losers as of 12:15 pm https://seekingalpha.com/news/3206905-consumer-goods-top-gainers-losers-of-12-15-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3206905-consumer-goods-top-gainers-losers-of-12-15-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3206901\" data-ts=\"1472831664\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NXST\" target=\"_blank\">NXST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3206901-nexstar-gets-antitrust-ok-for-4_6b-media-general-purchase\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nexstar gets antitrust OK for $4.6B Media General purchase</a></h4><ul>   <li>Nexstar Broadcast Group (NASDAQ:<a href=\"https://seekingalpha.com/symbol/NXST\" title=\"Nexstar Media Group, Inc.\">NXST</a>) has <a href=\"https://www.justice.gov/opa/pr/justice-department-requires-divestitures-order-nexstar-proceed-media-general-acquisition\" target=\"_blank\">gotten its antitrust approval</a> to buy Media General (NYSE:<a href=\"https://seekingalpha.com/symbol/MEG\" title=\"Media General\">MEG</a>) for $4.6B.</li>    <li>\n<a href=\"https://seekingalpha.com/symbol/NXST\" title=\"Nexstar Media Group, Inc.\">NXST</a> is <font color=\"green\">up 2.1%</font>; <a href=\"https://seekingalpha.com/symbol/MEG\" title=\"Media General\">MEG</a> is <font color=\"green\">up 1.5%</font> and just pennies off its 52-week high.</li>    <li>The Justice Dept. gave its OK today, conditioned on the fact that Nexstar must divest seven stations (in six markets) to upfront buyers that the department has approved. Without such divestitures, Justice says, ad prices and fees charged to MVPDs would increase in those markets.</li>    <li>Technically, the DOJ filed a civil antitrust suit simultaneously with a proposed settlement requiring Nexstar to sell WBAY in Green Bay to Gray Television; WSLS in Roanoke-Lynchburg to Graham Holdings; KADN and KLAF in Lafayette to Bayou City Broadcasting Lafayette; STHI in Terre Haute to USA Television MidAmerica Holdings; WFFT in Fort Wayne to USA Television; and KWQC in Quad Cities to Gray.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3187170-nexstar-selling-two-stations-gray-television-270m\" target=\"_blank\">Nexstar selling two stations to Gray Television for $270M</a> (Jun. 03 2016)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3186061-nexstar-divests-five-stations-aid-pursuit-media-general\" target=\"_blank\">Nexstar divests five stations to aid pursuit of Media General</a> (May. 27 2016)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3206901\" data-linked=\"Nexstar gets antitrust OK for $4.6B Media General purchase\" data-tweet=\"$NXST $NXST $MEG - Nexstar gets antitrust OK for $4.6B Media General purchase https://seekingalpha.com/news/3206901-nexstar-gets-antitrust-ok-for-4_6b-media-general-purchase?source=tweet\" data-url=\"https://seekingalpha.com/news/3206901-nexstar-gets-antitrust-ok-for-4_6b-media-general-purchase\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3206889\" data-ts=\"1472826686\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATVI\" target=\"_blank\">ATVI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3206889-activision-launching-big-call-of-duty-live-event-for-holiday-weekend\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Activision launching big &#39;Call of Duty&#39; live event for holiday weekend</a></h4><ul>   <li>In just a couple of hours, Activision (<a href=\"https://seekingalpha.com/symbol/ATVI\" title=\"Activision Blizzard, Inc\">ATVI</a> <font color=\"green\">+2.1%</font>) is opening Call of Duty XP, the huge in-person event tied to its multibillion-dollar war-game franchise, in Los Angeles.</li>    <li>Thousands of fans will gather at the weekend expo to play and livestream games with fans online, to absorb new content the company has gathered for the games (including hands-on on the upcoming release <i>Call of Duty: Infinite Warfare),</i> and take in a concert with Snoop Dogg and Wiz Khalifa.</li>    <li>Players are also wrapping the Call of Duty World League Championship, competing for prizes to be awarded Sunday that come to $2M.</li>    <li>\n<i>Call of Duty: Infinite Warfare</i> is arriving to high expectations on Nov. 4, alongside <i>Call of Duty: Modern Warfare Remastered.</i>\n</li>    <li>The company's also enjoying positive reaction to the release of <i>World of Warcraft's Legion,</i> released this week and injecting new life into another longtime franchise.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3206889\" data-linked=\"Activision launching big &#39;Call of Duty&#39; live event for holiday weekend\" data-tweet=\"$ATVI - Activision launching big &#39;Call of Duty&#39; live event for holiday weekend https://seekingalpha.com/news/3206889-activision-launching-big-call-of-duty-live-event-for-holiday-weekend?source=tweet\" data-url=\"https://seekingalpha.com/news/3206889-activision-launching-big-call-of-duty-live-event-for-holiday-weekend\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3206887\" data-ts=\"1472825727\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RCL\" target=\"_blank\">RCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3206887-carnival-sneezes-royal-caribbean-and-norwegian-cruise-catch-colds\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Carnival sneezes, Royal Caribbean and Norwegian Cruise catch colds</a></h4><ul><li>Carnival Corp is<font color='red'> lower 4.75%</font>&nbsp;after a <a href=\"https://seekingalpha.com/news/3206871-carnival-slumps-morgan-stanley-downgrade\" target=\"_blank\">downgrade to Underweight </a>from Morgan Stanley, whose survey of cruise travel agents showed neutral to negative booking trends for the important month of August, with agents for the first time noting the Zika virus as hurting business.</li><li>Royal Caribbean (<a href='https://seekingalpha.com/symbol/RCL' title='Royal Caribbean Cruises Ltd.'>RCL</a> <font color='red'>-2.4%</font>), Norwegian Cruise (<a href='https://seekingalpha.com/symbol/NCLH' title='Norwegian Cruise Line Holdings Ltd.'>NCLH</a> <font color='red'>-3.4%</font>)</li><li>Fading the moves of those giants, though, is Lindblad Expeditions (<a href='https://seekingalpha.com/symbol/LIND' title='Lindblad Expeditions Holdings Inc.'>LIND</a> <font color='green'>+1.9%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3206887\" data-linked=\"Carnival sneezes, Royal Caribbean and Norwegian Cruise catch colds\" data-tweet=\"$RCL $RCL $NCLH - Carnival sneezes, Royal Caribbean and Norwegian Cruise catch colds https://seekingalpha.com/news/3206887-carnival-sneezes-royal-caribbean-and-norwegian-cruise-catch-colds?source=tweet\" data-url=\"https://seekingalpha.com/news/3206887-carnival-sneezes-royal-caribbean-and-norwegian-cruise-catch-colds\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3206875\" data-ts=\"1472822616\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LULU\" target=\"_blank\">LULU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3206875-lululemonminus-8-sell-side-weighs-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lululemon -8% as sell-side weighs in</a></h4><ul>\n<li>Buy the dip, <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/09/8419179/barclays-positive-on-lululemons-q2-results\" target=\"_blank\">says Barclays' Matthew McClintock</a>, maintaining his Overweight rating and $85 price target, though cutting his 2016 and 2017 EPS estimates by a nickel each. Revenue growth of 13.6% was healthy; comps rose just 5%, but McClintock figures an online warehouse sale one year ago knocked 2% off this figure. Margin expansion of 260 basis points, however, topped expectations.</li>\n<li>Wedbush's Morry Brown <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/09/8419066/wedbush-says-lululemon-results-are-strong\" target=\"_blank\">defends as well</a>, also taking note of that online warehouse sale as causing the comp sales miss. Results show the company's \u201cability to generate strong comp sales growth despite a challenging external environment...The long promised gross margin inflection has now taken hold, with continued margin gains planned for H2 and into 2017.\u201d He maintains his Overweight rating and lifts the PT to $84 from $82.</li>\n<li>Promotions and light traffic should hamper the rest of the year, says FBR, <a href=\"http://www.streetinsider.com/Analyst+Comments/FBR+Keeps+Underperform+Rating+on+lululemon+%28LULU%29%3B+Promotions%2C+Light+Traffic+Should+Hamper+Rest+of+2016/11998135.html\" target=\"_blank\">maintaining its Underperform</a> rating and $40 price target.</li>\n<li>Maintaining his Neutral rating and $72 price target, <a href=\"http://www.streetinsider.com/Analyst+Comments/UBS+Remains+Sidelined+on+lululemon+athletica+%28LULU%29+Following+In-Line+2Q/11998508.html\" target=\"_blank\">UBS's Michael Binetti notes</a> same-store sales comps are going to be even harder in Q3 and Q4 of this year.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/LULU\" title=\"Lululemon Athletica Inc.\">LULU</a> <font color=\"red\">-8.15%</font> premarket</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3206753-lululemon-athletica-eps-line-misses-revenue\" target=\"_blank\">Lululemon Athletica EPS in-line, misses on revenue</a> (Sept. 1)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3206875\" data-linked=\"Lululemon -8% as sell-side weighs in\" data-tweet=\"$LULU - Lululemon -8% as sell-side weighs in https://seekingalpha.com/news/3206875-lululemonminus-8-sell-side-weighs-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3206875-lululemonminus-8-sell-side-weighs-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3206874\" data-ts=\"1472822492\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CCXI\" target=\"_blank\">CCXI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3206874-chemocentryxs-ccx872-appears-safe-in-early-stage-pancreatic-cancer-study-shares-off-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ChemoCentryx&#39;s CCX872 appears safe in early-stage pancreatic cancer study; shares off 10% premarket</a></h4><ul>\n<li>Thinly traded micro cap ChemoCentryx (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CCXI\" title=\"ChemoCentryx\">CCXI</a>) is off <font color=\"red\">10%</font> premarket on light volume, not unexpected considering the ~32% run-up since mid-August. After the close yesterday, the company released preliminary results from a Phase 1b clinical trial assessing CCX872 in 50 pancreatic cancer patients.</li>\n<li>The ongoing <a href=\"https://clinicaltrials.gov/ct2/show/NCT02345408?term=ccx872&amp;rank=1\" target=\"_blank\">open-label study</a> aims to evaluate the safety and effects of orally administered CCX872 when added to the chemo regimen FOLFIRINOX (5-fluorouracil, leucovorin, irinotecan and oxaliplatin) in patients with advanced non-resectable pancreatic cancer over a treatment period of 12 weeks. Per the protocol, subjects can continue to receive CCX872 for an indefinite period as long as there is no evidence of disease progression. Progression-free survival (PFS) data will be reported by year end.</li>\n<li>CCX872 was well-tolerated and demonstrated a safety profile consistent with FOLFIRINOX alone.</li>\n<li>Response data for the pre-specified evaluable patient population (n=41) (patients with at least one baseline CT scan) and the intent-to-treat population (n=50) (all patients, including those with no baseline CT scan) are provided as well, but isn't informative without response data in a population treated with FOLFIRINOX alone.</li>\n<li>\n<a href=\"http://www.chemocentryx.com/pipeline/immuno-oncology/cx872/\" target=\"_blank\">CCX872 </a>inhibits a chemokine receptor called CCR2 which is associated with tumor growth and angiogenesis (formation of new blood vessels).</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3206874\" data-linked=\"ChemoCentryx&#39;s CCX872 appears safe in early-stage pancreatic cancer study; shares off 10% premarket\" data-tweet=\"$CCXI - ChemoCentryx&#39;s CCX872 appears safe in early-stage pancreatic cancer study; shares off 10% premarket https://seekingalpha.com/news/3206874-chemocentryxs-ccx872-appears-safe-in-early-stage-pancreatic-cancer-study-shares-off-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3206874-chemocentryxs-ccx872-appears-safe-in-early-stage-pancreatic-cancer-study-shares-off-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3206872\" data-ts=\"1472822131\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3206872-premarket-gainers-losers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:10 am</a></h4><ul> <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ACW' title='Accuride Corporation'>ACW</a> <font color='green'>+55%</font>. <a href='https://seekingalpha.com/symbol/ATEC' title='Alphatec Holdings, Inc.'>ATEC</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/TCPI' title='TCP International'>TCPI</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/FSM' title='Fortuna Silver Mines'>FSM</a> <font color='green'>+6%</font>.</li> <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/PAY' title='VeriFone Systems, Inc.'>PAY</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a> <font color='red'>-8%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3206872\" data-linked=\"Premarket Gainers / Losers as of 9:10 am\" data-tweet=\"$ACW $ATEC $TCPI - Premarket Gainers / Losers as of 9:10 am https://seekingalpha.com/news/3206872-premarket-gainers-losers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3206872-premarket-gainers-losers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3206871\" data-ts=\"1472821918\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CCL\" target=\"_blank\">CCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3206871-carnival-slumps-after-morgan-stanley-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Carnival slumps after Morgan Stanley downgrade</a></h4><ul>\n<li>\n<a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/09/8419086/carnival-downgraded-at-morgan-stanley-agents-survey-show\" target=\"_blank\">The bank's qualitative survey of</a> cruise travel agents in the U.S. showed \"neutral to negative\" booking trends for August - typically one of the busiest months of the year for booking. The study also revealed ratings were falling, while promotions and agent incentives were growing.</li>\n<li>And although cruise lines deny it, some agents for the first time mentioned the Zika virus as a factor.</li>\n<li>Morgan Stanley downgrades <a href=\"https://seekingalpha.com/symbol/CCL\" title=\"Carnival Corporation\">CCL</a> to Underweight from Equalweight, and cuts the price target to $48 from $54.</li>\n<li>Shares <font color=\"red\">-3.7%</font> premarket to $46.90.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3206871\" data-linked=\"Carnival slumps after Morgan Stanley downgrade\" data-tweet=\"$CCL - Carnival slumps after Morgan Stanley downgrade https://seekingalpha.com/news/3206871-carnival-slumps-after-morgan-stanley-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3206871-carnival-slumps-after-morgan-stanley-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3206859\" data-ts=\"1472820172\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3206859-stocks-gold-bonds-higher-jobs-miss-likely-takes-sept-hike-off-table\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stocks, gold, bonds higher as jobs miss (likely) takes Sept. hike off table</a></h4><ul>\n<li>Nonfarm payrolls advanced just 151K in August vs. expectations for 180K, July's 255K gain was revised higher by 20K, and June's 292K gain was revised lower by 21K. The unemployment rate held steady at 4.9% vs. expectations for a decline to 4.8%.</li>\n<li>We'll call the report a modest miss. When combined with yesterday's surprising decline in the manufacturing PMI, a September rate hike appears to be off the table.</li>\n<li>Stocks are rallying, with S&amp;P 500 (NYSEARCA:<a href=\"https://seekingalpha.com/symbol/SPY\" title=\"SPDR S&amp;P 500 Trust ETF\">SPY</a>) futures now <font color=\"green\">higher by 0.35%</font>. Also on the move higher is gold (NYSEARCA:<a href=\"https://seekingalpha.com/symbol/GLD\" title=\"SPDR Gold Trust ETF\">GLD</a>), <font color=\"green\">up 1%</font> to $1,330 per ounce.</li>\n<li>The dollar (<a href=\"https://seekingalpha.com/symbol/UUP\" title=\"PowerShares DB USD Bull ETF\">UUP</a>, <a href=\"https://seekingalpha.com/symbol/UDN\" title=\"PowerShares DB USD Bear ETF\">UDN</a>) is <font color=\"red\">down 0.3%</font>.</li>\n<li>The 10-year Treasury yield (<a href=\"https://seekingalpha.com/symbol/TLT\" title=\"iShares 20+ Year Treasury Bond ETF\">TLT</a>, <a href=\"https://seekingalpha.com/symbol/TBT\" title=\"ProShares UltraShort 20+ Year Treasury ETF\">TBT</a>) has dipped three basis points since the report, now off one basis point on the session to 1.556%. <a href=\"http://www.cmegroup.com/trading/interest-rates/stir/30-day-federal-fund.html\" target=\"_blank\">Fed Funds futures</a> have made a sharp move higher, essentially pricing away any chance of a rate hike this month.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3206859\" data-linked=\"Stocks, gold, bonds higher as jobs miss (likely) takes Sept. hike off table\" data-tweet=\"$SPY $GLD $UUP - Stocks, gold, bonds higher as jobs miss (likely) takes Sept. hike off table https://seekingalpha.com/news/3206859-stocks-gold-bonds-higher-jobs-miss-likely-takes-sept-hike-off-table?source=tweet\" data-url=\"https://seekingalpha.com/news/3206859-stocks-gold-bonds-higher-jobs-miss-likely-takes-sept-hike-off-table\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>48&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":25,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}